PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 7, 2017
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2017-03-01+175,000→ 175,000 totalExercise: $11.32Exp: 2027-03-01→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]3yr 33% On Vest beginning on 01-Mar-2017